The Pentagon has signed a massive $210 million deal to purchase cluster shells from an Israeli state-owned arms company, Tomer. This marks the largest known contract of its kind between the US and Israel, with the deal set to be fulfilled over three years. The munitions are designed to replace decades-old cluster shells that have been widely criticized for their indiscriminate killing of civilians.
Cluster bombs, also known as cluster munitions, are designed to release small explosive devices called bomblets that can continue to detonate even after they have landed. This creates a hazardous environment for civilians who may be unaware of the danger posed by the unexploded devices, leading to long-term risks and humanitarian costs.
The deal is atypical because it was signed without public competition, with the US paying Tomer over three years to produce the new munitions. The company's previous attempt to produce a cluster bomb, known as the M999, was canceled after backlash from investors in countries that had signed the Convention on Cluster Munitions.
Advocates argue that cluster weapons are inherently indiscriminate and cannot be used responsibly due to their unpredictable nature. Researchers say that even if the new munition meets its claimed 1% failure rate target, it would still pose a significant humanitarian risk.
This deal highlights the ongoing issue of US support for Israel's military operations, which have been criticized for their impact on civilians. The sale of cluster munitions is particularly egregious given the harm they cause to innocent civilians, and calls for an end to their use are growing louder.
The Pentagon has defended its decision, saying that the new munition meets all performance requirements, including compliance with the DoD Cluster Munition Policy. However, critics argue that the policy itself is inadequate and that more needs to be done to prevent the use of cluster munitions in conflict zones.
As the Russia-Ukraine war continues to escalate, concerns about the role of cluster munitions are growing. The Convention on Cluster Munitions has been ratified by 112 countries, but major military powers such as the US, China, and Israel have not signed or adhered to it.
Cluster bombs, also known as cluster munitions, are designed to release small explosive devices called bomblets that can continue to detonate even after they have landed. This creates a hazardous environment for civilians who may be unaware of the danger posed by the unexploded devices, leading to long-term risks and humanitarian costs.
The deal is atypical because it was signed without public competition, with the US paying Tomer over three years to produce the new munitions. The company's previous attempt to produce a cluster bomb, known as the M999, was canceled after backlash from investors in countries that had signed the Convention on Cluster Munitions.
Advocates argue that cluster weapons are inherently indiscriminate and cannot be used responsibly due to their unpredictable nature. Researchers say that even if the new munition meets its claimed 1% failure rate target, it would still pose a significant humanitarian risk.
This deal highlights the ongoing issue of US support for Israel's military operations, which have been criticized for their impact on civilians. The sale of cluster munitions is particularly egregious given the harm they cause to innocent civilians, and calls for an end to their use are growing louder.
The Pentagon has defended its decision, saying that the new munition meets all performance requirements, including compliance with the DoD Cluster Munition Policy. However, critics argue that the policy itself is inadequate and that more needs to be done to prevent the use of cluster munitions in conflict zones.
As the Russia-Ukraine war continues to escalate, concerns about the role of cluster munitions are growing. The Convention on Cluster Munitions has been ratified by 112 countries, but major military powers such as the US, China, and Israel have not signed or adhered to it.